CEP76 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.04201108747293E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.45856676631229E-12 |
Normal-vs-Stage2 |
1.50429999999924E-05 |
Normal-vs-Stage3 |
6.72850664074076E-12 |
Normal-vs-Stage4 |
5.51469999998666E-07 |
Stage1-vs-Stage2 |
9.834600E-01 |
Stage1-vs-Stage3 |
2.474000E-02 |
Stage1-vs-Stage4 |
9.448000E-01 |
Stage2-vs-Stage3 |
2.060000E-01 |
Stage2-vs-Stage4 |
9.751600E-01 |
Stage3-vs-Stage4 |
1.538790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6521228829447E-12 |
Normal-vs-AfricanAmerican |
1.00629999999491E-06 |
Normal-vs-Asian |
1.300580E-01 |
Caucasian-vs-AfricanAmerican |
9.397200E-01 |
Caucasian-vs-Asian |
2.918400E-01 |
AfricanAmerican-vs-Asian |
3.686400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.60871316268185E-13 |
Normal-vs-Female |
1.03760000591535E-10 |
Male-vs-Female |
2.688000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.40170000000473E-05 |
Normal-vs-Age(41-60Yrs) |
4.03180000496661E-09 |
Normal-vs-Age(61-80Yrs) |
3.50099949031346E-11 |
Normal-vs-Age(81-100Yrs) |
5.74069999981219E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.027400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.154400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.451800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.980000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.514300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.816600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.352300E-02 |
Normal-vs-Grade 2 |
6.65480004435892E-10 |
Normal-vs-Grade 3 |
2.54689602741109E-11 |
Normal-vs-Grade 4 |
5.69360003588315E-09 |
Grade 1-vs-Grade 2 |
4.291000E-01 |
Grade 1-vs-Grade 3 |
1.153760E-01 |
Grade 1-vs-Grade 4 |
1.724200E-01 |
Grade 2-vs-Grade 3 |
7.823600E-02 |
Grade 2-vs-Grade 4 |
1.453010E-01 |
Grade 3-vs-Grade 4 |
7.736400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.64440025432577E-10 |
Normal-vs-ccB subtype |
1.3682055488573E-11 |
ccA subtype-vs-ccB subtype |
1.028230E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.7424952853703E-11 |
Normal-vs-N1 |
1.706050E-02 |
N0-vs-N1 |
4.529600E-01 |
|
|